190 results on '"Chrysant, S G"'
Search Results
2. Cardiovascular complications from consumption of high energy drinks: recent evidence
3. Treatment of hypertension with olmesartan medoxomil, alone and in combination with a diuretic: an update
4. Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence
5. Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan
6. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension
7. A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
8. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial
9. Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
10. Telcagepant does not reduce exercise tolerance in patients with exercise induced myocardial ischemia: P1424
11. Current status of angiotensin receptor blockers for thetreatment of cardiovascular diseases: focus on telmisartan
12. A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention
13. The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension
14. Cardiovascular complications from consumption of high energy drinks: recent evidence
15. TELMISARTAN 40 OR 80 MG/HCTZ 12.5 MG PROVIDE SUPERIOR AMBULATORY BP REDUCTIONS COMPARED TO LOSARTAN 50 MG/HCTZ 12.5 MG DURING THE LAST 6 HOURS OF THE DOSING INTERVAL
16. Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE study
17. Fixed Low-Dose Drug Combination for the Treatment of Hypertension
18. There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients
19. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension
20. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group
21. A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention.
22. Monotherapy of hypertension with darodipine: A new calcium-channel blocker.
23. Antihypertensive effectiveness of terazosin: A new long-acting alpha-adrenergic inhibitor.
24. The value of grip test as an index of autonomic function in hypertension.
25. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
26. Captopril stimulation of differential renins in renovascular hypertension.
27. Racial differences in pressure, volume and renin interrelationships in essential hypertension.
28. Evaluation of Antihypertensive Efficacy of Lisinopril Compared to Metoprolol in Moderate to Severe Hypertension.
29. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
30. Long-Term Efficacy, Safety, and Tolerability of Valsartan and Hydrochlorothiazide in Patients with Essential Hypertension
31. Long-Term Antihypertensive Effects with Chronic Administration of Isradipine Controlled Release
32. Lisinopril dose-response relationship in essential hypertension
33. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature
34. Withdrawal of antihypertensive therapy
35. Natriuresis and Carbohydrate-Induced Antinatriuresis in Fasted, Hydrated Hypertensives
36. Systemic hemodynamic effects of bethanidine in essential hypertension.
37. Effects of High Salt Intake and Meclofenamate on Arterial Pressure and Renal Function in the Spontaneously Hypertensive Rat
38. Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences
39. Hemodynamic correlates of saralasin-induced arterial pressure changes.
40. Sustained blood pressure control with controlled-release isradipine.
41. Letter: Withdrawal of clonidine.
42. P-445: CS-866 versus losartan, valsartan, and irbesartan in patients with essential hypertension.
43. Efficacy and Safety of Extended-Release Isosorbide Mononitrate for Stable Effort Angina Pectoris
44. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.
45. Superior antihypertensive and cardioprotective effects of chlorthalidone compared with hydrochlorothiazide.
46. Unintended consequences of the new ACC/AHA blood pressure treatment guidelines.
47. Controversies regarding the cardiovascular effects of testosterone replacement therapy in older men.
48. Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs.
49. The impact of SPRINT on the future treatment of hypertension: a mini review.
50. Current status of β-blockers for the treatment of hypertension: an update.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.